Association study between the genetic polymorphisms of glutathione-related enzymes and schizophrenia in a Japanese population

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 150, Issue 1, 2009, Pages 86-94

  Matsuzawa, Daisuke ^a   Hashimoto, Kenji ^a   Hashimoto, Tasuku ^a   Shimizu, Eiji ^a   Watanabe, Hiroyuki ^a   Fujita, Yuko ^a   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Glutathione; Oxidative stress; Polymorphism; Schizophrenia; Susceptibility

Indexed keywords

GLUTATHIONE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; ETHNICITY; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; GLUTATHIONE METABOLISM; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; BASE SEQUENCE; DNA PRIMERS; FEMALE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SCHIZOPHRENIA;

EID: 58849096261     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30776     Document Type: Article

References (57)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). Washington, DC: American Psychiatric Association.
2. Arinami T, Ohtsuki T, Ishiguro H, Ujike H, Tanaka Y, Morita Y, Mineta M, Takeichi M, Yamada S, Imamura A, Ohara K, Shibuya H, Ohara K, Suzuki Y, Muratake T, Kaneko N, Someya T, Inada T, Yoshikawa T, Toyota T, Yamada K, Kojima T, Takahashi S, Osamu O, Shinkai T, Nakamura M, Fukuzako H, Hashiguchi T, Niwa SI, Ueno T, Tachikawa H, Hori T, Asada T, Nanko S, Kunugi H, Hashimoto R, Ozaki N, Iwata N, Harano M, Arai H, Ohnuma T, Kusumi I, Koyama T, Yoneda H, Fukumaki Y, Shibata H, Kaneko S, Higuchi H, Yasui-Furukori N, Numachi Y, Itokawa M, Okazaki Y, Japanese Schizophrenia Sib-Pair Linkage Group. 2005. Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am J Hum Genet 77:937-944.
3. Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B. 1997. Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J 324(Pt1): 25-28.
4. Buchanan RW. 2007. Persistent negative symptoms in schizophrenia: An overview. Schizophr Bull 33:1013-1022.
5. Buckman TD, Kling AS, Eiduson S, Sutphin MS, Steinberg A. 1987. Glutathione peroxidase and CT scan abnormalities in schizophrenia. Biol Psychiatry 22:1349-1356.
6. Carter CJ. 2006. Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability. Schizophr Res 86: 1-14.
7. Do KQ, Trabesinger AH, Kirsten-Kruger M, Lauer CJ, Dydak U, Hell D, Holsboer F, Boesiger P, Cuenod M. 2000. Schizophrenia: Glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 12:3721-3728.
8. Dringen R. 2000a. Glutathione metabolism and oxidative stress in neurodegeneration. Eur J Biochem 267:4903.
9. Dringen R. 2000b. Metabolism and functions of glutathione in brain. Prog Neurobiol 62:649-671.
10. Forsberg L, de Faire U, Morgenstern R. 2001. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys 389:84-93.
11. Gilliland FD, Gauderman WJ, Vora H, Rappaport E, Dubeau L. 2002. Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth. Am J Respir Crit Care Med 166:710-716.
12. Harada S, Tachikawa H, Kawanishi Y. 2001. Glutathione S-transferase M1 gene deletion may be associated with susceptibility to certain forms of schizophrenia. Biochem Biophys Res Commun 281:267-271.
13. Hashimoto T, Hashimoto K, Matsuzawa D, Shimizu E, Sekine Y, Inada T, Ozaki N, Iwata N, Harano M, Komiyama T, Yamada M, Sora I, Ujike H, Iyo M. 2005. A functional glutathione S-transferase P1 gene polymorphism is associated with methamphetamine-induced psychosis in Japanese population. Am J Med Genet Part B 135B:5-9.
14. Hayes JD, Strange RC. 2000. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61:154-166.
15. Hu Y, Benya RV, Carroll RE, Diamond AM. 2005. Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer. J Nutr 135:3021S-3024S.
16. Huang CS, Chang LS, Anderson ME, Meister A. 1993. Catalytic and regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine synthetase. J Biol Chem 268:19675-19680.
17. Ichimura Y, Habuchi T, Tsuchiya N, Wang L, Oyama C, Sato K, Nishiyama H, Ogawa O, Kato T. 2004. Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant. J Urol 172:728-732.
18. Kirkpatrick B, Buchanan RW, Ross DE, Carpenter WT. 2001. A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 58:165-171.
19. Klivenyi P, Andreassen OA, Ferrante RJ, Dedeoglu A, Mueller G, Lancelot E, Bogdanov M, Andersen JK, Jiang D, Beal MF. 2000. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. J Neurosci 20:1-7.
20. Kolsch H, Linnebank M, Lutjohann D, Jessen F, Wullner U, Harbrecht U, Thelen KM, Kreis M, Hentschel F, Schulz A, von Bergmann K, Maier W, Heun R. 2004. Polymorphisms in glutathione S-transferase omega-1 and AD, vascular dementia, and stroke. Neurology 63:2255-2260.
21. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, O'Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lonnqvist J, Peltonen L, O'Donovan MC, Owen MJ, Wildenauer DB, Maier W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy-Friedman JM, Svrakic DM, Bassett AS, Holcomb J, Kalsi G, McQuillin A, Brynjolfson J, Sigmundsson T, Petursson H, Jazin E, Zoega T, Helgason T. 2003. Genome scan metaanalysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 73:34-48.
22. Li YJ, Oliveira SA, Xu P, Martin ER, Stenger JE, Scherzer CR, Hauser MA, Scott WK, Small GW, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, Mastaglia F, Middleton LT, Roses AD, Saunders AM, Schmechel DE, Gullans SR, Haines JL, Gilbert JR, Vance JM, Pericak-Vance MA, Hulette C, Welsh-Bohmer KA. 2003. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet 12:3259-3267.
23. Mahadik SP, Mukherjee S. 1996. Free radical pathology and antioxidant defense in schizophrenia: A review. Schizophr Res 19:1-17.
24. Mannervik B. 1985. The isoenzymes of glutathione transferase. Adv Enzymol Relat Areas Mol Biol 57:357-417.
25. Marnell LL, Garcia-Vargas GG, Chowdhury UK, Zakharyan RA, Walsh B, Avram MD, Kopplin MJ, Cebrian ME, Silbergeld EK, Aposhian HV. 2003. Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/hGSTO1 gene and changes in urinary arsenic profiles. Chem Res Toxicol 16:1507-1513.
26. Matsuzawa D, Hashimoto K, Shimizu E, Fujisaki M, Iyo M. 2005. Functional polymorphism of the glutathione peroxidase 1 gene is associated with personality traits in healthy subjects. Neuropsychobiology 52: 68-70.
27. Meister A, Anderson ME. 1983. Glutathione. Annu Rev Biochem 52: 711-760.
28. Mulcrone J, Whatley SA, Marchbanks R, Wildenauer D, Altmark D, Daoud H, Gur E, Ebstein RP, Lerer B. 1995. Genetic linkage analysis of schizophrenia using chromosome 11q 13-24markers in Israeli pedigrees. Am J Med Genet 60:103-108.
29. Nakamura S, Kugiyama K, Sugiyama S, Miyamoto S, Koide S, Fukushima H, Honda O, Yoshimura M, Ogawa H. 2002. Polymorphism in the 50-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction. Circulation 105: 2968-2973.
30. Nakazato H, Suzuki K, Matsui H, Koike H, Okugi H, Ohtake N, Takei T, Nakata S, Hasumi M, Ito K, Kurokawa K, Yamanaka H. 2003. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population. Anticancer Res 23:2897-2902.
31. Pae CU, Kim JJ, Lee SJ, Lee CU, Lee C, Paik IH, Park HR, Yang S, Serretti A. 2003. Association study between glutathione S-transferase P1 polymorphism and schizophrenia in the Korean population. Prog Neuropsychopharmacol Biol Psychiatry 27:519-523.
32. Pae CU, Yu HS, Kim JJ, Kim W, Lee CU, Lee SJ, Jun TY, Lee C, Paik IH, Serretti A. 2004. Glutathione S-transferase M1 polymorphism may contribute to schizophrenia in the Korean population. Psychiatr Genet 14:147-150.
33. Raimondi S, Paracchini V, Autrup H, Barros-Dios JM, Benhamou S, Boffetta P, Cote ML, Dialyna IA, Dolzan V, Filiberti R, Garte S, Hirvonen A, Husgafvel-Pursiainen K, Imyanitov EN, Kalina I, Kang D, Kiyohara C, Kohno T, Kremers P, Lan Q, London S, Povey AC, Rannug A, Reszka E, Risch A, Romkes M, Schneider J, Seow A, Shields PG, Sobti RC, Sorensen M, Spinola M, Spitz MR, Strange RC, Stucker I, Sugimura H, To-Figueras J, Tokudome S, Yang P, Yuan JM, Warholm M, Taioli E. 2006. Meta- and pooled analysis of GSTT1 and lung cancer: A HuGE-GSEC review. Am J Epidemiol 164:1027-1042.
34. Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, Debsikdar VB, Mahadik SP. 2003. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 121:109-122.
35. Ravn-Haren G, Olsen A, Tjonneland A, Dragsted LO, Nexo BA, Wallin H, Overvad K, Raaschou-Nielsen O, Vogel U. 2006. Associations between GPX1 Pro198Leu polymorphism, erythrocyte GPX activity, alcohol consumption and breast cancer risk in a prospective cohort study. Carcinogenesis 27:820-825.
36. Risch A, Wikman H, Thiel S, Schmezer P, Edler L, Drings P, Dienemann H, Kayser K, Schulz V, Spiegelhalder B, Bartsch H. 2001. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. Pharmacogenetics 11:757-764.
37. Saadat M, Mobayen F, Farrashbandi H. 2007. Genetic polymorphism of glutathione S-transferase T1: A candidate genetic modifier of individual susceptibility to schizophrenia. Psychiatry Res 153:87-91.
38. Schulz JB, Lindenau J, Seyfried J, Dichgans J. 2000. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267:4904-4911.
39. Schweizer U, Brauer AU, Kohrle J, Nitsch R, Savaskan NE. 2004. Selenium and brain function: A poorly recognized liaison. Brain Res Brain Res Rev 45:164-178.
40. Shaw SH, Kelly M, Smith AB, Shields G, Hopkins PJ, Loftus J, Laval SH, Vita A, De Hert M, Cardon LR, Crow TJ, Sherrington R, DeLisi LE. 1998. A genome-wide search for schizophrenia susceptibility genes. Am J Med Genet 81:364-376.
41. Shinkai T, De Luca V, Zai G, Shaikh S, Matsumoto C, Arnold PD, Hwang R, King N, Trakalo J, Potapova N, Wong G, Hori H, Wong AH, Ohmori O, Nakamura J, Kennedy JL. 2004. No association between the Pro197Leu polymorphism in the glutathione peroxidase (GPX1) gene and schizophrenia. Psychiatr Genet 14:177-180.
42. Shinkai T, De Luca V, Hwang R, Matsumoto C, Hori H, Ohmori O, Remington G, Meltzer HY, Lieberman JA, Potkin SG, Nakamura J, Kennedy JL. 2005. Association study between a functional glutathione S-transferase (GSTP1) gene polymorphism (Ile105Val) and tardive dyskinesia. Neurosci Lett 388:116-120.
43. Smeyne M, Boyd J, Raviie Shepherd K, Jiao Y, Pond BB, Hatler M, Wolf R, Henderson C, Smeyne RJ. 2007. GSTpi expression mediates dopaminergic neuron sensitivity in experimental Parkinsonism. Proc Natl Acad Sci USA 104:1977-1982.
44. Smythies JR. 1997. Oxidative reactions and schizophrenia: A review-discussion. Schizophr Res 24:357-364.
45. Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR, Pillai MR. 2001. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol 37:593-598.
46. Strange RC, Spiteri MA, Ramachandran S, Fryer AA. 2001. Glutathione-S-transferase family of enzymes. Mutat Res 482:21-26.
47. Tanaka-Kagawa T, Jinno H, Hasegawa T, Makino Y, Seko Y, Hanioka N, Ando M. 2003. Functional characterization of two variant human GSTO 1-1s (Ala140Asp and Thr217Asn). Biochem Biophys Res Commun 301:516-520.
48. Tosic M, Ott J, Barral S, Bovet P, Deppen P, Gheorghita F, Matthey ML, Parnas J, Preisig M, Saraga M, Solida A, Timm S, Wang AG, Werge T, Cuenod M, Do KQ. 2006. Schizophrenia and oxidative stress: Glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet 79: 586-592.
49. Wahner AD, Glatt CE, Bronstein JM, Ritz B. 2007. Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease. Neurosci Lett 413:274-278.
50. Watson MA, Stewart RK, Smith GB, Massey TE, Bell DA. 1998. Human glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19:275-280.
51. Whitbread AK, Tetlow N, Eyre HJ, Sutherland GR, Board PG. 2003. Characterization of the human omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics 13:131-144.
52. Whitbread AK, Masoumi A, Tetlow N, Schmuck E, Coggan M, Board PG. 2005. Characterization of the omega class of glutathione transferases. Methods Enzymol 401:78-99.
53. Yang Y, Dieter MZ, Chen Y, Shertzer HG, Nebert DW, Dalton TP. 2002. Initial characterization of the glutamate-cysteine ligase modifier subunit gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response. J Biol Chem 277:49446-49452.
54. Yao JK, Reddy RD, van Kammen DP. 2001. Oxidative damage and schizophrenia: An overview of the evidence and its therapeutic implications. CNS Drugs 15:287-310.
55. Yao JK, Leonard S, Reddy R. 2006. Altered glutathione redox state in schizophrenia. Dis Markers 22:83-93.
56. Yoshimura K, Hanaoka T, Ohnami S, Ohnami S, Kohno T, Liu Y, Yoshida T, Sakamoto H, Tsugane S. 2003. Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: Data from population-based Japanese random samples. J Hum Genet 48:654-658.
57. Zhang XY, Tan YL, Zhou DF, Cao LY, Wu GY, Haile CN, Kosten TA, Kosten TR. 2007. Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia. J Clin Psychiatry 68:754-760.